Carpenter Technology
CRS NYSE Industrial Machinery & Supplies & Components Financials FY2017βFY2026
Carpenter Technology's revenue rose 8.6% to $3.1 billion in fiscal 2026. Its operating margin was 22.5%, up from 18.1% a year earlier. Free cash flow was $362 million, up 26.6%. It paid out $219 million in dividends and buybacks, 61% of free cash flow. The diluted share count fell 0.6%.
What Carpenter Technology does
No business description yet.
- Legal name
- CARPENTER TECHNOLOGY CORPORATION
- Fiscal year ends
- June 30, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0000017843-26-000034
0000017843
Revenue and margins
Carpenter Technology had $3.1B of revenue in fiscal 2026, up 8.6% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 30.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $362M in fiscal 2026, 11.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Carpenter Technology returned $219M to shareholders in fiscal 2026, 61% of free cash flow. The diluted share count fell 0.6%.
Value Carpenter Technology yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$297M and divides by 50.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 25.1x Β· peers 32.3x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Carpenter Technology can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $154M | $44.5M | $199M | $316M | $393M |
| Debt incl. finance leases | $692M | $693M | $694M | $695M | $691M |
| Net debt / EBITDA | 5.1x | 2.5x | 1.1x | 0.6x | 0.4x |
| Debt / equity | 0.5x | 0.5x | 0.4x | 0.4x | 0.3x |
| Interest coverage | β0.6x | 2.5x | 6.3x | 10.8x | 18.6x |
| Current ratio | 3.0x | 2.8x | 3.4x | 3.7x | 3.8x |
| Quick ratio | 1.7x | 1.4x | 1.8x | 2.0x | 2.2x |
| Total assets | $2.9B | $3.1B | $3.3B | $3.5B | $3.8B |
| Total liabilities | $1.6B | $1.7B | $1.7B | $1.6B | $1.6B |
| Shareholders' equity | $1.3B | $1.4B | $1.6B | $1.9B | $2.2B |
| Net debt (β = net cash) | $538M | $649M | $495M | $380M | $297M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$92.9M
7 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Steven E KarolDirector | Sold | 3,275 | $474.08 | $1.6M | Form 4 |
| Aug 25, 2026 | Tony R TheneChairman, President and CEO, Director | Sold | 109,283 | $483.84 | $52.9M | Form 4 |
| Aug 21, 2026 | Ramin YounessiDirector | Sold | 438 | $493.15 | $0.2M | Form 4 |
| Jun 1, 2026 | Steven E KarolDirector | Sold | 2,000 | $487.74 | $1.0M | Form 4 |
| May 28, 2026 | Anastasios John HartDirector | Sold | 250 | $461.88 | $0.1M | Form 4 |
| May 5, 2026 | Marshall D AkinsVP and Chief Comm Officer | Sold | 11,815 | $441.36 | $5.2M | Form 4 |
| May 4, 2026 | Anastasios John HartDirector | Sold | 750 | $423.86 | $0.3M | Form 4 |
| Feb 24, 2026 | James D DeeSVP, Gen Counsel & Sec | Sold | 15,800 | $391.78 | $6.2M | Form 4 |
| Feb 19, 2026 | Steven E KarolDirector | Sold | 6,500 | $380.60 | $2.5M | Form 4 |
| Dec 11, 2025 | Brian J MalloyPresident and COO | Sold | 4,130 | $303.52 | $1.3M | Form 4 |
| Dec 10, 2025 | Brian J MalloyPresident and COO | Sold | 43,688 | $304.46 | $13.3M | Form 4 |
| Dec 9, 2025 | Brian J MalloyPresident and COO | Sold | 27,640 | $305.60 | $8.4M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 7 / 9 | 9 / 9 |
| Accruals ratio | β2.8% | β1.9% | β2.1% |
| Altman Z'' | 5.29 | 6.25 | 7.05 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Carpenter Technology CRS | $14.2B | 8.6% | 22.5% | 11.6% | 23.7% | 25.1x | 9 | |
| Middleby MIDD | $5.1B | 1.6% | 18.0% | 17.5% | 8.7% | β | 4 | Compare β |
| ESAB ESAB | $4.1B | 3.7% | 14.5% | 7.5% | 11.0% | 24.1x | 4 | Compare β |
| IDEX IEX | $17.0B | 5.8% | 20.2% | 17.8% | 10.2% | 33.0x | 7 | Compare β |
| Nordson NDSN | $17.9B | 3.8% | 25.5% | 23.7% | 11.6% | 32.3x | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.8B | $2.2B | $2.4B | $2.2B | $1.5B | $1.8B | $2.6B | $2.8B | $2.9B | $3.1B |
| Gross profit | $301M | $382M | $445M | $329M | $1.0M | $150M | $337M | $584M | $769M | $956M |
| Research and development | $16.9M | $19.3M | $23.3M | $28.0M | $19.7M | $20.4M | $24.4M | $25.6M | $26.1M | $27.7M |
| Operating income | $122M | $189M | $241M | $25.3M | β$249M | β$24.9M | $133M | $323M | $522M | $702M |
| Interest expense | $29.8M | $28.3M | $26.0M | $19.8M | $32.7M | $44.9M | $54.1M | $51.0M | $48.4M | $37.8M |
| Pretax income | $70.2M | $160M | $216M | $6.1M | β$298M | β$63.1M | $72.5M | $212M | $467M | $656M |
| Income tax | $23.2M | β$28.3M | $49.0M | $4.6M | β$68.3M | β$14.0M | $16.1M | $25.1M | $91.3M | $126M |
| Net income | $47.0M | $189M | $167M | $1.5M | β$230M | β$49.1M | $56.4M | $187M | $376M | $530M |
| Diluted EPS | $0.99 | $3.92 | $3.43 | $0.02 | β$4.76 | β$1.01 | $1.14 | $3.70 | $7.42 | $10.52 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $130M | $209M | $232M | $232M | $250M | $6.0M | $14.7M | $275M | $440M | $605M |
| Capital expenditure | $98.5M | $135M | $180M | $171M | $101M | $91.3M | $82.3M | $96.6M | $154M | $243M |
| Free cash flow | $31.8M | $74.2M | $52.1M | $60.4M | $150M | β$85.3M | β$67.6M | $178M | $286M | $362M |
| Depreciation and amortization | $118M | $117M | $122M | $124M | $124M | $131M | $131M | $135M | $139M | $147M |
| Stock-based compensation | $13.0M | $17.6M | $17.6M | $10.9M | $10.4M | $10.8M | $16.4M | $19.8M | $22.8M | $26.4M |
| Acquisitions | $35.3M | $13.3M | $79.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $102M | $179M |
| Dividends paid | $34.1M | $34.4M | $38.6M | $38.8M | $39.1M | $39.2M | $39.4M | $40.0M | $40.3M | $40.3M |
| Dividends and buybacks | $34.1M | $34.4M | $38.6M | $38.8M | $39.1M | $39.2M | $39.4M | $40.0M | $142M | $219M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $66.3M | $56.2M | $27.0M | $193M | $287M | $154M | $44.5M | $199M | $316M | $393M |
| Total debt | $605M | $546M | $570M | $722M | $695M | $692M | $693M | $694M | $695M | $691M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.1B | $1.2B | $1.2B | $1.3B | $1.1B | $1.1B | $1.3B | $1.6B | $1.8B | $2.0B |
| Current liabilities | $396M | $363M | $416M | $452M | $306M | $376M | $459M | $466M | $484M | $520M |
| Inventory | $690M | $689M | $788M | $724M | $426M | $496M | $640M | $735M | $794M | $823M |
| Property and equipment, net | $1.3B | $1.3B | $1.4B | $1.5B | $1.5B | $1.4B | $1.4B | $1.3B | $1.4B | $1.5B |
| Total assets | $2.9B | $3.0B | $3.2B | $3.2B | $3.0B | $2.9B | $3.1B | $3.3B | $3.5B | $3.8B |
| Total liabilities | $1.7B | $1.5B | $1.7B | $1.8B | $1.6B | $1.6B | $1.7B | $1.7B | $1.6B | $1.6B |
| Shareholders' equity | $1.2B | $1.5B | $1.5B | $1.4B | $1.4B | $1.3B | $1.4B | $1.6B | $1.9B | $2.2B |
| Margins | ||||||||||
| Gross margin | 16.7% | 17.7% | 18.7% | 15.1% | 0.1% | 8.2% | 13.2% | 21.2% | 26.7% | 30.6% |
| Operating margin | 6.8% | 8.8% | 10.1% | 1.2% | β16.9% | β1.4% | 5.2% | 11.7% | 18.1% | 22.5% |
| EBITDA margin | 13.3% | 14.2% | 15.3% | 6.8% | β8.5% | 5.8% | 10.4% | 16.6% | 23.0% | 27.2% |
| Net margin | 2.6% | 8.7% | 7.0% | 0.1% | β15.6% | β2.7% | 2.2% | 6.8% | 13.1% | 17.0% |
| FCF margin | 1.8% | 3.4% | 2.2% | 2.8% | 10.1% | β4.7% | β2.7% | 6.5% | 9.9% | 11.6% |
| Returns | ||||||||||
| Return on capital | 4.8% | 10.2% | 9.2% | 0.6% | β10.4% | β1.1% | 5.3% | 13.7% | 19.1% | 23.7% |
| Return on capital employed | 4.9% | 7.4% | 8.9% | 0.9% | β9.1% | β1.0% | 5.2% | 11.9% | 17.9% | 22.2% |
| Return on equity | 4.1% | 14.0% | 11.1% | 0.1% | β16.2% | β3.6% | 4.1% | 12.3% | 21.4% | 25.8% |
| Return on assets | 1.7% | 6.4% | 5.4% | 0.1% | β7.4% | β1.7% | 1.9% | 5.9% | 11.1% | 14.5% |
| Growth | ||||||||||
| Revenue growth | β0.9% | 20.0% | 10.3% | β8.4% | β32.4% | 24.4% | 38.9% | 8.2% | 4.3% | 8.6% |
| Net income growth | 315.9% | 301.1% | β11.4% | β99.1% | β15,406.7% | β | β | 230.7% | 101.6% | 40.9% |
| EPS growth | 330.4% | 296.0% | β12.5% | β99.4% | β23,900.0% | β | β | 224.6% | 100.5% | 41.8% |
| FCF growth | β80.4% | 133.3% | β29.8% | 15.9% | 147.5% | β157.1% | β | β | 60.5% | 26.6% |
| Share count change | β2.3% | 1.1% | 1.1% | 0.2% | 0.2% | 0.4% | 1.4% | 2.2% | 0.8% | β0.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.3x | 1.6x | 1.5x | 3.5x | β | 5.1x | 2.5x | 1.1x | 0.6x | 0.4x |
| Debt / equity | 0.5x | 0.4x | 0.4x | 0.5x | 0.5x | 0.5x | 0.5x | 0.4x | 0.4x | 0.3x |
| Interest coverage | 4.1x | 6.7x | 9.3x | 1.3x | β7.6x | β0.6x | 2.5x | 6.3x | 10.8x | 18.6x |
| Current ratio | 2.8x | 3.2x | 3.0x | 2.8x | 3.7x | 3.0x | 2.8x | 3.4x | 3.7x | 3.8x |
| Quick ratio | 1.0x | 1.4x | 1.1x | 1.2x | 2.3x | 1.7x | 1.4x | 1.8x | 2.0x | 2.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.5% | 6.3% | 7.6% | 7.9% | 6.8% | 5.0% | 3.2% | 3.5% | 5.4% | 7.8% |
| Stock comp / revenue | 0.7% | 0.8% | 0.7% | 0.5% | 0.7% | 0.6% | 0.6% | 0.7% | 0.8% | 0.9% |
| Payouts / FCF | 107.2% | 46.4% | 74.1% | 64.2% | 26.2% | β | β | 22.4% | 49.7% | 60.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 8.0 | 8.0 | 6.0 | 3.0 | 4.0 | 5.0 | 6.0 | 8.0 | 7.0 | 9.0 |
| Altman Z'' | 4.1 | 4.8 | 4.8 | 4.1 | 3.6 | 3.8 | 4.3 | 5.3 | 6.3 | 7.1 |
| Accruals ratio | β2.9% | β0.7% | β2.1% | β7.2% | β15.5% | β1.9% | 1.4% | β2.8% | β1.9% | β2.1% |
Source: SEC EDGAR XBRL filings (CIK 0000017843). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.